Journal of Pediatric Surgery
Volume 37, Issue 7 , Pages 949-954 , July 2002

Mass screening for neuroblastoma in Japan: Lessons learned and future directions

Presented at the 53rd Annual Meeting of the Section on Surgery of the American Academy of Pediatrics, San Francisco, California, October 19-21, 2001.

References 

  1. Sawada T, Kidowaki T, Sakamoto I, et al.  Neuroblastoma: Mass screening for early detection and its prognosis. Cancer. 1984;53:2731–2735
  2. Bessho F, Hashizume K, Nakajo T, et al.  Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr. 1991;119:237–241
  3. Matsumura T, Shikata T, Sawada T. Treatment modality for neuroblastoma infants in Japan: Retrospective analysis and future directions. Proceedings of the 31st American Society of Clinical Oncology. J Clin Oncol. 1995;14:456
  4. Yamamoto K, Hayashi Y, Hanada R, et al.  Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan. Acta Paediatr Jpn. 1995;84:1173–1176
  5. Suita S, Zaizen Y, Sera Y, et al.  Mass screening for neuroblastoma: Quo Vadis? A 9-year experience from the pediatric oncology study group of the Kyushu area in Japan. J Pediatr Surg. 1996;31:555–558
  6. Evans AE, D'Angio GJ, Randolph JA. A proposed staging for children with neuroblastoma: Children's Cancer Study Group A. Cancer. 1971;27:374–378
  7. Suita S, Tajiri T, Sera Y, et al.  Improved survival in advanced neuroblastoma following high dose combined chemotherapy based in part upon MYCN amplification. J Pediatr Surg. 2000;35:1737–1741
  8. Shimada H, Chatten J, Newton WA, et al.  Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglio-neuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst. 1984;73:405–416
  9. Tajiri T, Suita S, Sera Y, et al.  Clinical and biological characteristics for relapsed neuroblastoma at mass screening cases in Japan. Cancer. 2001;92:349–353
  10. Suita S, Tajiri T, Akazawa K, et al.  Mass screening for neuroblastoma at 6 months of age: Difficult to justify. J Pediatr Surg. 1998;33:1674–1678
  11. Yamamoto K, Hanada R, Tanimura M, et al.  Natural history of neuroblastoma found by mass screening. Lancet. 1997;349:1102
  12. Suita S, Sawada T, Kaneko M, et al.  The report of the committee for neuroblastoma at the Japanese association of Pediatric Oncology at 1998. Jpn J Pediatr Oncol. 1999;36:107–117

 Address reprint requests to Sachiyo Suita, MD, PhD, FACS, Pediatric Surgery, Reproductive and Developmental Medicine, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

PII: S0022-3468(02)00001-5

doi: 10.1053/jpsu.2002.33814

Journal of Pediatric Surgery
Volume 37, Issue 7 , Pages 949-954 , July 2002